Westlake BioPartners Fund I, L.P.
SEC CIK 1749591 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LTGO | Latigo Biotherapeutics, Inc. | 10% | 2.09M | — | — | 1 | 2026-08-10 | 2026-08-10 |
Most active insiders at LTGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foresite Capital Management V, LLC | 10% | $2.52M | — |
| 2 | Tananbaum James B. | Dir, 10% | $2.52M | — |
| 3 | 5AM Ventures VI, L.P. | 10% | — | — |
| 4 | Westlake BioPartners Fund I, L.P. | 10% | — | — |
| 5 | SEIDENBERG BETH C | Dir, 10% | — | — |
| 6 | Sanofi | 10% | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-11 06:00 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. | 10% | C - Cnv Deriv | — | +12.70M | 2.09M | New | — |
Purchase Sale Sale after option exercise All abbreviations